Skip to content
EntityQ6036513· pop 5· linked from 114 articles

Inogatran (INN) is a low molecular weight peptidomimetic thrombin inhibitor. Inogatran was developed for the potential treatment of arterial and venous thrombotic diseases.

Wikidata facts

Mass
438.295
Show 4 more facts
canonical SMILES
C1CCC(CC1)CC(C(=O)N2CCCCC2C(=O)NCCCN=C(N)N)NCC(=O)O
isomeric SMILES
C1CCC(CC1)C[C@H](C(=O)N2CCCC[C@H]2C(=O)NCCCN=C(N)N)NCC(=O)O
chemical formula
C₂₁H₃₈N₆O₄
Commons category
Inogatran
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

1 sections
Contents
  • References

{{chembox | ImageFile = Inogatran.svg | ImageClass = skin-invert-image | ImageSize = 275px | ImageAlt = | IUPACName = 2-{[(2R)-1-[(2S)-2-[(4-Carbamimidamidopropyl)carbamoyl]piperidin-1-yl]-3-cyclohexyl-1-oxopropan-2-yl]amino}acetic acid | OtherNames = N-[(1R)-2-Cyclohexyl-1-[[(2S)-2-[(3-guanidinopropyl)carbamoyl]piperidino]carbonyl]ethyl]glycine

| Section1 =

Excerpted from Wikipedia’s “inogatran” article, available under the CC BY-SA 4.0 licence.

Available in 4 languages

via Wikidata sitelinks · CC0